Disease, Disability, and Injury Prevention and Control; Special Interest Projects (SIPs): Initial Review, 29351-29352 [2012-11952]

Download as PDF 29351 Federal Register / Vol. 77, No. 96 / Thursday, May 17, 2012 / Notices Number of respondents Type of respondent Form name Prospective Study Participant ................................................. Prospective Study Participant ................................................. Prospective Study Participant ................................................. Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Pre-Screening Form ............... Full-Screening Form ............... Brief Locator Form ................. Record Locator Form ............. Baseline Assessment ............. 3-month Follow-up Assessment. 6-month Follow-up Assessment. Participant Evaluation Forms Exit Survey ............................. Exit Interview .......................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Kimberly S. Lane, Deputy Director, Office of Science Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. a.m. to 5:30 p.m., EST and Thursday, June 21, 2012 from 8:30 a.m. to 1:00 p.m. EST. Logistics: The Task Force Meeting will be held at the Emory Conference Center’s at 1615 Clifton Road Atlanta, GA 30329. Information regarding logistics will be available on the Community Guide Web site (www.thecommunityguide.org), Wednesday, May 23, 2012. [FR Doc. 2012–11878 Filed 5–16–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention FOR FURTHER INFORMATION CONTACT: Meeting of the Community Preventive Services Task Force (CPSTF) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC) announces the next meeting of the Community Preventive Services Task Force (CPSTF). The Task Force—an independent, nonfederal body of nationally known leaders in public health practice, policy, and research, who are appointed by the CDC Director—was convened in 1996 by the Department of Health and Human Services (HHS) to assess the effectiveness of community, environmental, population, and healthcare system interventions in public health and health promotion. During this meeting, the Task Force will consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. The Task Force’s recommendations, along with the systematic reviews of the scientific evidence on which they are based, are compiled in the Guide to Community Preventive Services (Community Guide). DATES: The meeting will be held on Wednesday, June 20, 2012 from 8:30 mstockstill on DSK6TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:20 May 16, 2012 Jkt 226001 Allyson Brown, The Community Guide Branch, Epidemiology and Analysis Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Road, MS–E– 69, Atlanta, Georgia 30333, phone: (404) 498–0937), email: CPSTF@cdc.gov. Purpose: The purpose of the meeting is for the Task Force to consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. Matters To Be Discussed: Updates on Cancer, Motor vehicle-related injuries, Tobacco, Health Equity, and Alcohol. Meeting Accessibility: This meeting is open to the public, limited only by space availability. Dated: May 3, 2012. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2012–11938 Filed 5–16–12; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Number responses per respondent Average burden per respondent (in hours) 333 172 172 146 146 132 1 1 1 1 1 1 5/60 10/60 5/60 10/60 1 1 117 1 1 146 117 10 6 1 1 5/60 10/60 30/60 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control; Special Interest Projects (SIPs): Initial Review The meeting announced below concerns Examination of Environmental Characteristics that Enable and/or Promote Frequent Indoor Tanning among Young Adults to Inform Future Public Health Policy Efforts to Prevent Skin Cancer, SIP12–054, Pilot Study to Evaluate Strategies for Reducing Medical Radiation Exposure in Children, SIP12–055, and Innovative Message Framing to Increase Support for Evidence-based Tobacco Control, SIP12–060, Panel A, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date 11:00 a.m.–5:30 p.m., June 20, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Examination of Environmental Characteristics that Enable and/or Promote Frequent Indoor Tanning among Young Adults to Inform Future Public Health Policy Efforts to Prevent Skin Cancer, SIP12–054, Pilot Study to Evaluate Strategies for Reducing Medical Radiation Exposure in E:\FR\FM\17MYN1.SGM 17MYN1 29352 Federal Register / Vol. 77, No. 96 / Thursday, May 17, 2012 / Notices Children, SIP12–055, and Innovative Message Framing to Increase Support for Evidence-based Tobacco Control, SIP12–060, Panel A, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 10, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–11952 Filed 5–16–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–0473] Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the Production, Processing, and Handling of Food AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA’s requirements for food irradiation processors. mstockstill on DSK6TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:20 May 16, 2012 Jkt 226001 Submit either electronic or written comments on the collection of information by July 16, 2012. ADDRESSES: Submit electronic comments on the collection of information to https:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400T, Rockville, MD 20850, 301–796– 5733, domini.bean@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501–3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, DATES: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 when appropriate, and other forms of information technology. Irradiation in the Production, Processing, and Handling of Food—21 CFR Part 179 (OMB Control Number 0910–0186)—Extension Under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 321(s) and 348), food irradiation is subject to regulation under the food additive premarket approval provisions of the FD&C Act. The regulations providing for uses of irradiation in the production, processing, and handling of food are found in part 179 (21 CFR part 179). To ensure safe use of a radiation source, § 179.21(b)(1) requires that the label of sources bear appropriate and accurate information identifying the source of radiation and the maximum (or minimum and maximum) energy of radiation emitted by X-ray tube sources. Section 179.21(b)(2) requires that the label or accompanying labeling bear adequate directions for installation and use and a statement supplied by FDA that indicates maximum dose of radiation allowed. Section 179.26(c) requires that the label or accompanying labeling bear a logo and a radiation disclosure statement. Section 179.25(e) requires that food processors who treat food with radiation make and retain, for 1 year past the expected shelf life of the products up to a maximum of 3 years, specified records relating to the irradiation process (e.g., the food treated, lot identification, scheduled process, etc.). The records required by § 179.25(e) are used by FDA inspectors to assess compliance with the regulation that establishes limits within which radiation may be safely used to treat food. The Agency cannot ensure safe use without a method to assess compliance with the dose limits, and there are no practicable methods for analyzing most foods to determine whether they have been treated with ionizing radiation and are within the limitations set forth in part 179. Records inspection is the only way to determine whether firms are complying with the regulations for treatment of foods with ionizing radiation. Description of respondents: Respondents are businesses engaged in the irradiation of food. FDA estimates the burden of this collection of information as follows: E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 77, Number 96 (Thursday, May 17, 2012)]
[Notices]
[Pages 29351-29352]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11952]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control; Special 
Interest Projects (SIPs): Initial Review

    The meeting announced below concerns Examination of Environmental 
Characteristics that Enable and/or Promote Frequent Indoor Tanning 
among Young Adults to Inform Future Public Health Policy Efforts to 
Prevent Skin Cancer, SIP12-054, Pilot Study to Evaluate Strategies for 
Reducing Medical Radiation Exposure in Children, SIP12-055, and 
Innovative Message Framing to Increase Support for Evidence-based 
Tobacco Control, SIP12-060, Panel A, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Time and Date

    11:00 a.m.-5:30 p.m., June 20, 2012 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Examination of Environmental 
Characteristics that Enable and/or Promote Frequent Indoor Tanning 
among Young Adults to Inform Future Public Health Policy Efforts to 
Prevent Skin Cancer, SIP12-054, Pilot Study to Evaluate Strategies for 
Reducing Medical Radiation Exposure in

[[Page 29352]]

Children, SIP12-055, and Innovative Message Framing to Increase Support 
for Evidence-based Tobacco Control, SIP12-060, Panel A, initial 
review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-46, 
Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 10, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-11952 Filed 5-16-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.